Have a personal or library account? Click to login
Movement Disorders and Oculomotor Abnormalities in Whipple’s Disease: An Updated Systematic Review Cover

Movement Disorders and Oculomotor Abnormalities in Whipple’s Disease: An Updated Systematic Review

Tremor and Other Hyperkinetic Movements
Volume 15 (2025): Issue 1
By: Errikos MasliasORCID,  Ruben Anker,  Philipp EuskirchenORCID,  Karin DiserensORCID and  Julien F. BallyORCID  
Open Access
|Nov 2025

References

  1. 1Uryu K, Sakai T, Yamamoto T, Mae T, Willard YI, Sugita H, et al. Central nervous system relapse of Whipple’s disease. Intern Med Tokyo Jpn. 2012;51(15):2045–50. DOI: 10.2169/internalmedicine.51.7304
    Back to article
  2. 2Biagi F, Trotta L, Corazza GR. Whipple’s disease. Intern Emerg Med. 2012;7(Suppl 3):S209–213. DOI: 10.1007/s11739-012-0801-1
    Back to article
  3. 3Amendolara M, Barbarino C, Bucca D, Stevanato G, Zucchelli M, Romano F, et al. Whipple’s disease infection surgical treatment: presentation of a rare case and literature review. Il G Chir. 2013;34(4):117–21.
    Back to article
  4. 4Marth T, Moos V, Müller C, Biagi F, Schneider T. Tropheryma whipplei infection and Whipple’s disease. Lancet Infect Dis. 2016;16(3):e13–22. DOI: 10.1016/S1473-3099(15)00537-X
    Back to article
  5. 5Puechal X, London J. Clinical Image: Whipple’s Destructive Septic Arthritis. Arthritis Rheumatol Hoboken NJ. United States. 2017;69(3):559. DOI: 10.1002/art.39999
    Back to article
  6. 6Peters G, du Plessis DG, Humphrey PR. Cerebral Whipple’s disease with a stroke-like presentation and cerebrovascular pathology. J Neurol Neurosurg Psychiatry. 2002;73(3):336–9. DOI: 10.1136/jnnp.73.3.336
    Back to article
  7. 7Schnider P, Trattnig S, Kollegger H, Auff E. MR of cerebral Whipple disease. AJNR Am J Neuroradiol [Internet]. 1995 [cited 2025 May 26];16(6):1328–9. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8337820/
    Back to article
  8. 8Marth T. New insights into Whipple’s disease – a rare intestinal inflammatory disorder. Dig Dis Basel Switz. 2009;27(4):494–501. DOI: 10.1159/000233288
    Back to article
  9. 9Fenollar F, Puéchal X, Raoult D. Whipple’s disease. N Engl J Med. 2007;356(1):55–66. DOI: 10.1056/NEJMra062477
    Back to article
  10. 10Schneider T, Moos V, Loddenkemper C, Marth T, Fenollar F, Raoult D. Whipple’s disease: new aspects of pathogenesis and treatment. Lancet Infect Dis. 2008;8(3):179–90. DOI: 10.1016/S1473-3099(08)70042-2
    Back to article
  11. 11Magherini A, Pentore R, Grandi M, Leone ME, Nichelli PF. Progressive supranuclear gaze palsy without parkinsonism: a case of neuro-Whipple. Parkinsonism Relat Disord. 2007;13(7):449–52. DOI: 10.1016/j.parkreldis.2006.05.035
    Back to article
  12. 12Moos V, Schneider T. Changing paradigms in Whipple’s disease and infection with Tropheryma whipplei. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol. 2011;30(10):1151–8. DOI: 10.1007/s10096-011-1209-y
    Back to article
  13. 13Panegyres PK, Edis R, Beaman M, Fallon M. Primary Whipple’s disease of the brain: characterization of the clinical syndrome and molecular diagnosis. QJM Mon J Assoc Physicians. 2006;99(9):609–23. DOI: 10.1093/qjmed/hcl081
    Back to article
  14. 14Weisfelt M, Oosterwerff E, Oosterwerff M, Verburgh C. Whipple’s disease presenting with neurological symptoms in an immunosuppressed patient. BMJ Case Rep. 2012;2012:bcr0220125882. DOI: 10.1136/bcr.02.2012.5882
    Back to article
  15. 15Verhagen WI, Huygen PL, Dalman JE. Central nervous system Whipple’s disease. Ann Neurol. 1997;41(4):560–1. DOI: 10.1002/ana.410410424
    Back to article
  16. 16Verhagen WI, Huygen PL, Dalman JE, Schuurmans MM. Whipple’s disease and the central nervous system. A case report and a review of the literature. Clin Neurol Neurosurg. 1996;98(4):299–304. DOI: 10.1016/0303-8467(96)00035-2
    Back to article
  17. 17Rossi T, Haghighipour R, Haghighi M, Paolini S, Scarpino O. Cerebral Whipple’s disease as a cause of reversible dementia. Clin Neurol Neurosurg. 2005;107(3):258–61. DOI: 10.1016/j.clineuro.2004.10.014
    Back to article
  18. 18Labiano-Fontcuberta A, Benito-León J. Whipple’s disease: Multiple systemic and neurological relapses. Reply. Neurol Engl Ed. Elsevier. 2012;27(6):376. DOI: 10.1016/j.nrleng.2012.07.006
    Back to article
  19. 19Domínguez RO, Müller C, Davolos I, MacKeith P, Arias E, Taratuto AL. Enfermedad de Whipple: Múltiples recaídas sistémicas y neurológicas. Neurología. Elsevier. 2013;28(1):57–9. DOI: 10.1016/j.nrl.2011.04.009
    Back to article
  20. 20Sung VW, Lyerly MJ, Fallon KB, Bashir K. Isolated CNS Whipple disease with normal brain MRI and false-positive CSF 14-3-3 protein: a case report and review of the literature. Brain Behav. 2012;2(6):838–43. DOI: 10.1002/brb3.97
    Back to article
  21. 21Gerard A, Sarrot-Reynauld F, Liozon E, Cathebras P, Besson G, Robin C, et al. Neurologic presentation of Whipple disease: report of 12 cases and review of the literature. Medicine (Baltimore). 2002;81(6):443–57. DOI: 10.1097/00005792-200211000-00005
    Back to article
  22. 22Zalonis I, Christidi F, Potagas C, Rentzos M, Evdokimidis I, Kararizou E. Central Nervous System Involvement as Relapse in Undiagnosed Whipple’s Disease with Atypical Symptoms at Onset. Open Neurol J. 2015;9:21–3. DOI: 10.2174/1874205X01509010021
    Back to article
  23. 23Vital Durand D, Gérard A, Rousset H. Neurological manifestations of Whipple disease. Rev Neurol (Paris). 2002;158(10 Pt 1):988–92.
    Back to article
  24. 24Strupp M, Kremmyda O, Adamczyk C, Böttcher N, Muth C, Yip CW, et al. Central ocular motor disorders, including gaze palsy and nystagmus. J Neurol. 2014;261(Suppl 2):S542–558. DOI: 10.1007/s00415-014-7385-9
    Back to article
  25. 25França MC, Castro R de, Balthazar MLF, Malveira GLS, Pirani C, Deus-Silva L, et al. Whipple’s disease with neurological manifestations: case report. Arq Neuropsiquiatr. 2004;62(2A):342–6. DOI: 10.1590/S0004-282X2004000200028
    Back to article
  26. 26Louis ED, Lynch T, Kaufmann P, Fahn S, Odel J. Diagnostic guidelines in central nervous system Whipple’s disease. Ann Neurol. 1996;40(4):561–8. DOI: 10.1002/ana.410400404
    Back to article
  27. 27Arce E, Paulson G. Blepharospasm and vertical ophthalmoparesis as presenting symptoms in whipple’s disease: report of a case. Neurologist. 1999;5:33–6. DOI: 10.1097/00127893-199901000-00006
    Back to article
  28. 28Barbero-Aznarez P, Perez-Tanoira R, Aguirre-Mollehuanca D, Trascasa-Caño A, Fortes-Alen J, Manzarbeitia-Arrambari F, et al. Isolated central nervous system Whipple disease. Surg Neurol Int. 2022;13:477. DOI: 10.25259/SNI_591_2022
    Back to article
  29. 29Lagier J-C, Fenollar F, Lepidi H, Giorgi R, Million M, Raoult D. Treatment of classic Whipple’s disease: from in vitro results to clinical outcome. J Antimicrob Chemother. 2014;69(1):219–27. DOI: 10.1093/jac/dkt310
    Back to article
  30. 30Moos V, Krüger J, Allers K, Moter A, Kikhney J, Kühl AA, et al. Oral treatment of Whipple’s disease with doxycycline and hydroxychloroquine versus intravenous therapy with ceftriaxone followed by oral trimethoprim–sulfamethoxazole in Germany: a phase 2/3, prospective, open-label, randomised, controlled, non-inferiority trial. Lancet Infect Dis. 2025;S1473309924007977. DOI: 10.1016/S1473-3099(24)00797-7
    Back to article
  31. 31Bally JF, Meneret A, Roze E, Anderson M, Grabli D, Lang AE. Systematic review of movement disorders and oculomotor abnormalities in Whipple’s disease. Mov Disord Off J Mov Disord Soc. United States. 2018;33(11):1700–11. DOI: 10.1002/mds.27419
    Back to article
  32. 32Mecklenburg J, Moos V, Moter A, Siebert E, Nave AH, Schneider T, et al. The spectrum of central nervous system involvement in Whipple’s disease. Eur J Neurol. 2023;30(11):3417–29. DOI: 10.1111/ene.15511
    Back to article
  33. 33Campagnolo M, Tognon S, Pompanin S, Sattin A, Cagnin A, Briani C. Whipple’s disease without gastrointestinal symptoms: a challenging diagnosis. J Neurol. Germany. 2016;263(8):1657–8. DOI: 10.1007/s00415-016-8184-2
    Back to article
  34. 34Schnider PJ, Reisinger EC, Gerschlager W, Müller C, Berger T, Krejs GJ, et al. Long-term follow-up in cerebral Whipple’s disease. Eur J Gastroenterol Hepatol. 1996;8(9):899–903.
    Back to article
  35. 35Brown AP, Lane JC, Murayama S, Vollmer DG. Whipple’s disease presenting with isolated neurological symptoms. Case report. J Neurosurg. 1990;73(4):623–7. DOI: 10.3171/jns.1990.73.4.0623
    Back to article
  36. 36Henning S, Tings T, Schmidt H, Tergau F, Wolf S, Scholz K, et al. A case of cerebral Whipple’s disease initially presenting with isolated focal myoclonus. Eur J Neurol. 2006;13(6):659–61. DOI: 10.1111/j.1468-1331.2006.01396.x
    Back to article
  37. 37Van Bogaert L, Lafon R, Pages P, Labauge R. Sur une encephalite subaigue non classable, principalement caracterisee par des myoryhtmies oculo-facio-cervicales. Rev Neurol Paris. 1963;(109):443–53.
    Back to article
  38. 38Schwartz MA, Selhorst JB, Ochs AL, Beck RW, Campbell WW, Harris JK, et al. Oculomasticatory myorhythmia: a unique movement disorder occurring in Whipple’s disease. Ann Neurol. 1986;20(6):677–83. DOI: 10.1002/ana.410200605
    Back to article
  39. 39Revilla FJ, de la Cruz R, Khardori N, Espay AJ. Teaching NeuroImage: Oculomasticatory myorhythmia: pathognomonic phenomenology of Whipple disease. Neurology. 2008;70(6):e25. DOI: 10.1212/01.wnl.0000287142.16160.0f
    Back to article
  40. 40Baizabal-Carvallo JF, Cardoso F, Jankovic J. Myorhythmia: phenomenology, etiology, and treatment. Mov Disord Off J Mov Disord Soc. 2015;30(2):171–9. DOI: 10.1002/mds.26093
    Back to article
  41. 41López Domíngue D, Silva Blas Y, Marco Cazcarra C, Puig Casadevall M. Oculomasticatory Myorhythmia, an Underrecognized Yet Key Finding for the Topographic and Etiological Diagnosis in Patients with Rhombencephalitis. Videographic Record of a Case. Mov Disord Clin Pract. 2021;8(8):1258–9. DOI: 10.1002/mdc3.13343
    Back to article
  42. 42Matthews BR, Jones LK, Saad DA, Aksamit AJ, Josephs KA. Cerebellar ataxia and central nervous system whipple disease. Arch Neurol. 2005;62(4):618–20. DOI: 10.1001/archneur.62.4.618
    Back to article
  43. 43Panegyres PK. Diagnosis and management of Whipple’s disease of the brain. Pract Neurol. 2008;8(5):311–7. DOI: 10.1136/jnnp.2008.156836
    Back to article
  44. 44Lugassy MM, Louis ED. Neurologic manifestations of Whipple’s disease. Curr Infect Dis Rep. 2006;8(4):301–6. DOI: 10.1007/s11908-006-0075-8
    Back to article
  45. 45Panegyres PK, Goh J. Sleep disorders of Whipple’s disease of the brain. QJM Int J Med. 2015;108(2):99–103. DOI: 10.1093/qjmed/hcu149
    Back to article
  46. 46Voderholzer U, Riemann D, Gann H, Hornyak M, Juengling F, Schumacher M, et al. Transient total sleep loss in cerebral Whipple’s disease: a longitudinal study. J Sleep Res. 2002;11(4):321–9. DOI: 10.1046/j.1365-2869.2002.00311.x
    Back to article
  47. 47Boban M, Gjadrov-Kuvezdic K, Jakic-Razumovic J. Cytology of cerebrospinal fluid in CNS Whipple disease. Acta Neurol Belg. Italy. 2017;117(4):935–6. DOI: 10.1007/s13760-017-0824-5
    Back to article
  48. 48Kobayashi T, Amram AL, Gehrs K, Diekema D, Barker J. A 52-Year-Old Man with Uveitis and Altered Mental Status. Clin Infect Dis. 2021;72(5):873–5. DOI: 10.1093/cid/ciaa051
    Back to article
  49. 49Testi I, Tognon MS, Gupta V. Ocular Whipple Disease: Report of Three Cases. Ocul Immunol Inflamm. 2019;27(7):1117–20. DOI: 10.1080/09273948.2018.1518461
    Back to article
  50. 50Balaini N, Goel A, Aleti S, Takkar A, Rastogi P, Singh H, et al. Whipple Disease and Orbital Inflammatory Syndrome – A Case Report. J Neuroophthalmol. 2024;44(1):E105–7. DOI: 10.1097/WNO.0000000000001724
    Back to article
  51. 51Fenollar F, Laouira S, Lepidi H, Rolain J-M, Raoult D. Value of Tropheryma whipplei quantitative polymerase chain reaction assay for the diagnosis of Whipple disease: usefulness of saliva and stool specimens for first-line screening. Clin Infect Dis Off Publ Infect Dis Soc Am. 2008;47(5):659–67. DOI: 10.1086/590559
    Back to article
  52. 52Günther U, Moos V, Offenmüller G, Oelkers G, Heise W, Moter A, et al. Gastrointestinal diagnosis of classical Whipple disease: clinical, endoscopic, and histopathologic features in 191 patients. Medicine (Baltimore). 2015;94(15):e714. DOI: 10.1097/MD.0000000000000714
    Back to article
  53. 53Meersseman W, Verschueren P, Tousseyn T, De Vos R, Cassiman D. PAS-positive macrophages--not always infection. Lancet Lond Engl. 2011;377(9780):1890. DOI: 10.1016/S0140-6736(11)60285-7
    Back to article
  54. 54de Oliveira Santana MA, Butt S, Nassiri M. Central Nervous System Whipple Disease Presenting as Hypersomnolence. Cureus. United States. 2022;14(3):e23572. DOI: 10.7759/cureus.23572
    Back to article
  55. 55Lagier J-C, Lepidi H, Raoult D, Fenollar F. Systemic Tropheryma whipplei: clinical presentation of 142 patients with infections diagnosed or confirmed in a reference center. Medicine (Baltimore). 2010;89(5):337–45. DOI: 10.1097/MD.0b013e3181f204a8
    Back to article
  56. 56von Herbay A, Ditton HJ, Schuhmacher F, Maiwald M. Whipple’s disease: staging and monitoring by cytology and polymerase chain reaction analysis of cerebrospinal fluid. Gastroenterology. 1997;113(2):434–41. DOI: 10.1053/gast.1997.v113.pm9247461
    Back to article
  57. 57Steele J, Richardson J, Olszewski J. Progressive Supranuclear Palsy: A Heterogeneous Degeneration Involving the Brain Stem, Basal Ganglia and Cerebellum With Vertical Gaze and Pseudobulbar Palsy, Nuchal Dystonia and Dementia. Arch Neurol. 1964;10(4):333–59. DOI: 10.1001/archneur.1964.00460160003001
    Back to article
  58. 58Höglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, et al. Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria. Mov Disord Off J Mov Disord Soc. 2017;32(6):853–64. DOI: 10.1002/mds.26987
    Back to article
  59. 59Averbuch-Heller L, Paulson GW, Daroff RB, Leigh RJ. Whipple’s disease mimicking progressive supranuclear palsy: the diagnostic value of eye movement recording. J Neurol Neurosurg Psychiatry. 1999;66(4):532–5. DOI: 10.1136/jnnp.66.4.532
    Back to article
  60. 60Bally JF, Lang AE. Reader response: IgLON5-mediated neurodegeneration is a differential diagnosis of CNS Whipple disease. Neurology. United States. 2019;92(11):544. DOI: 10.1212/WNL.0000000000007087
    Back to article
  61. 61Morales-Briceno H, Cruse B, Fois AF, Lin M-W, Jiang J, Banerjee D, et al. IgLON5-mediated neurodegeneration is a differential diagnosis of CNS Whipple disease. Neurology. United States. 2018;90(24):1113–5. DOI: 10.1212/WNL.0000000000005679
    Back to article
  62. 62Gaig C, Compta Y, Heidbreder A, Marti MJ, Titulaer MJ, Crijnen Y, et al. Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease. Neurology. 2021;97(14):e1367–81. DOI: 10.1212/WNL.0000000000012639
    Back to article
  63. 63Honorat JA, Komorowski L, Josephs KA, Fechner K, St Louis EK, Hinson SR, et al. IgLON5 antibody: Neurological accompaniments and outcomes in 20 patients. Neurol Neuroimmunol Neuroinflammation. 2017;4(5):e385. DOI: 10.1212/NXI.0000000000000385
    Back to article
  64. 64Xia C, Duquette A, Frucht S, Lafontaine A-L. Whipple’s disease presenting with segmental myoclonus and hypersomnia. Mov Disord Off J Mov Disord Soc. 2012;27(10):1216–7. DOI: 10.1002/mds.24039
    Back to article
  65. 65Asioli GM, Calandra-Buonaura G, Mastrangelo V, Pierangeli G, Gaig C, Santamaria J, et al. Persistence of Facio-Skeletal Myorhythmia During Sleep in anti-IgLON5 Disease. Mov Disord Clin Pract. 2021;8(3):460–3. DOI: 10.1002/mdc3.13159
    Back to article
  66. 66Colosimo C, Morgante L, Antonini A, Barone P, Avarello TP, Bottacchi E, et al. Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study. J Neurol. 2010;257(1):5–14. DOI: 10.1007/s00415-009-5255-7
    Back to article
  67. 67Alster P, Madetko-Alster N, Migda A, Migda B, Kutyłowski M, Królicki L, et al. Sleep disturbances in progressive supranuclear palsy syndrome (PSPS) and corticobasal syndrome (CBS). Neurol Neurochir Pol. 2023;57(3):229–34. DOI: 10.5603/PJNNS.a2023.0019
    Back to article
  68. 68Katirji B. Peripheral nerve hyperexcitability. Handb Clin Neurol. 2019;161:281–90. DOI: 10.1016/B978-0-444-64142-7.00054-0
    Back to article
  69. 69Ure RJ, Dhanju S, Lang AE, Fasano A. Unusual tremor syndromes: know in order to recognise. J Neurol Neurosurg Psychiatry. 2016;87(11):1191–203. DOI: 10.1136/jnnp-2015-311693
    Back to article
  70. 70Bhattacharjee S. Palatal Tremor – Pathophysiology, Clinical Features, Investigations, Management and Future Challenges. Tremor Hyperkinetic Mov N Y N. 2020;10:40. DOI: 10.5334/tohm.188
    Back to article
  71. 71Biller J, Espay AJ. Nosography of the ‘essential’: volitional palatal tremor. Neurology. 2013;81(8):772–3. DOI: 10.1212/WNL.0b013e3182a1aab3
    Back to article
  72. 72Jha V, Makharia A, Garg D, Agarwal A, Radhakrishnan DM, Pandit AK, et al. Palatal Tremor, Periocular and Perioral Myokymia, and Pseudoathetosis in a Patient with Whipple’s Disease. Ann Indian Acad Neurol. 2024;27(4):463–4. DOI: 10.4103/aian.aian_206_24
    Back to article
  73. 73Etemadifar M, Sabouri M, Zarepour M, Akhavan Sigari A, Salari M. Facial involvement in multiple sclerosis. Mult Scler Relat Disord. 2022;67:104110. DOI: 10.1016/j.msard.2022.104110
    Back to article
  74. 74Feurle GE, Junga NS, Marth T. Efficacy of Ceftriaxone or Meropenem as Initial Therapies in Whipple’s Disease. Gastroenterology. 2010;138(2):478–86. DOI: 10.1053/j.gastro.2009.10.041
    Back to article
  75. 75Fenollar F, Perreal C, Raoult D. Tropheryma whipplei natural resistance to trimethoprim and sulphonamides in vitro. Int J Antimicrob Agents. 2014;43(4):388–90. DOI: 10.1016/j.ijantimicag.2014.01.015
    Back to article
  76. 76Lagier J-C, Fenollar F, Lepidi H, Raoult D. Failure and relapse after treatment with trimethoprim/sulfamethoxazole in classic Whipple’s disease. J Antimicrob Chemother. 2010;65(9):2005–12. DOI: 10.1093/jac/dkq263
    Back to article
  77. 77Hujoel IA, Johnson DH, Lebwohl B, Leffler D, Kupfer S, Wu T-T, et al. Tropheryma whipplei Infection (Whipple Disease) in the USA. Dig Dis Sci. United States. 2019;64(1):213–23. DOI: 10.1007/s10620-018-5033-4
    Back to article
DOI: https://doi.org/10.5334/tohm.1075 | Journal eISSN: 2160-8288
Journal RSS Feed
Language: English
Submitted on: Jul 13, 2025
Accepted on: Oct 12, 2025
Published on: Nov 11, 2025
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Whipple’s disease,
central nervous system,
movement disorders,
oculomotor abnormalities,
systematic review

© 2025 Errikos Maslias, Ruben Anker, Philipp Euskirchen, Karin Diserens, Julien F. Bally, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 15 (2025): Issue 1